|
|
Volumn 3, Issue 6, 2001, Pages 24-36
|
|
Treatment of hepatitis B
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALCOHOL;
ALPHA FETOPROTEIN;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
ASPARTATE AMINOTRANSFERASE;
BETA INTERFERON;
DNA POLYMERASE;
FAMCICLOVIR;
GAMMA INTERFERON;
HEMOGLOBIN;
HEPATITIS B ANTIGEN;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
HEPATITIS B(E) ANTIBODY;
HEPATITIS B(E) ANTIGEN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
LAMIVUDINE;
LIVER ENZYME;
LIVER PROTEIN;
NUCLEOSIDE DERIVATIVE;
PROTHROMBIN;
TOXIN;
VIRUS ANTIBODY;
VIRUS DNA;
ADULT;
ARTICLE;
BLOOD ANALYSIS;
CHEMOPROPHYLAXIS;
CHILD;
CHRONIC HEPATITIS;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MECHANISM;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
INFECTION RISK;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TOXICITY;
NONHUMAN;
ONSET AGE;
RISK ASSESSMENT;
SERODIAGNOSIS;
SIDE EFFECT;
STRAIN DIFFERENCE;
TREATMENT INDICATION;
VIRUS INFECTIVITY;
VIRUS MUTATION;
VIRUS REPLICATION;
VIRUS STRAIN;
|
|
EID: 0034889733
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(01)90076-6 Document Type: Article |
|
Times cited : (10)
|
|
References (7)
|
